Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.11 and traded as high as $0.16. Enzon Pharmaceuticals shares last traded at $0.16, with a volume of 47,000 shares changing hands.
Enzon Pharmaceuticals Stock Performance
The stock has a fifty day moving average price of $0.16 and a 200-day moving average price of $0.11. The firm has a market capitalization of $12.44 million, a PE ratio of 16.76 and a beta of 0.52.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Featured Stories
- Five stocks we like better than Enzon Pharmaceuticals
- CD Calculator: Certificate of Deposit Calculator
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- What is the Hang Seng index?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- How Investors Can Find the Best Cheap Dividend Stocks
- MarketBeat Week in Review – 7/29 – 8/2
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
